Camlin Fine Sciences (NSE:CAMLINFINE) Debt-to-Equity: N/A (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:CAMLINFINE Camlin Fine Sciences Ltd NSE:CAMLINFINE
63 GF Score
Price ₹102.80
GF Value ₹145.78
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Camlin Fine Sciences Debt-to-Equity?

Camlin Fine Sciences's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was ₹0 Mil. Camlin Fine Sciences's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was ₹0 Mil. Camlin Fine Sciences's Total Stockholders Equity for the quarter that ended in Jun. 2026 was ₹0 Mil.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Camlin Fine Sciences's Debt-to-Equity or its related term are showing as below:

NSE:CAMLINFINE' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.69   Med: 1   Max: 1.87
Current: 0.69

During the past 13 years, the highest Debt-to-Equity Ratio of Camlin Fine Sciences was 1.87. The lowest was 0.69. And the median was 1.00.

NSE:CAMLINFINE's Debt-to-Equity is ranked worse than
71.88% of 1419 companies
in the Chemicals industry
Industry Median: 0.36 vs NSE:CAMLINFINE: 0.69

Camlin Fine Sciences  (NSE:CAMLINFINE) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Camlin Fine Sciences Debt-to-Equity Related Terms

Camlin Fine Sciences Debt-to-Equity Historical Data

* Premium members only.

The historical data trend for Camlin Fine Sciences's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Camlin Fine Sciences Debt-to-Equity Chart

Camlin Fine Sciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.86 0.98 0.79 0.72 0.69

Camlin Fine Sciences Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A 0.76 N/A 0.69 N/A

NSE:CAMLINFINE vs LIN, SHW, ECL: Debt-to-Equity Comparison

For the Specialty Chemicals subindustry, Camlin Fine Sciences's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Camlin Fine Sciences Debt-to-Equity vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Camlin Fine Sciences's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Camlin Fine Sciences's Debt-to-Equity falls into.


NSE:CAMLINFINE
63GF Score
Camlin Fine Sciences Ltd NSE:CAMLINFINE
Debt-to-Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Camlin Fine Sciences Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Camlin Fine Sciences's Debt to Equity Ratio for the fiscal year that ended in Mar. 2026 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(3830.845 + 3370.081) / 10408.801
=0.69

Camlin Fine Sciences's Debt to Equity Ratio for the quarter that ended in Jun. 2026 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0) / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Camlin Fine Sciences (NSE:CAMLINFINE) Overvalued in 2026?

Based on GuruFocus' analysis, Camlin Fine Sciences stock appears to be undervalued. The current stock price of ₹102.80 is trading 29.5% below its estimated GF Value™ of ₹145.78. GuruFocus considers Camlin Fine Sciences to be Modestly Undervalued.

Key valuation signals for NSE:CAMLINFINE:

  • Debt-to-Equity: N/A
  • GF Value™: ₹145.78 vs. price of ₹102.80 (29.5% below fair value)
  • GF Score™: 63/100 with 5 warning signs

No single metric tells the full story. See the NSE:CAMLINFINE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Camlin Fine Sciences Business Description

Other Exchanges 532834:India
Address CST Road, Kalina, Floor 2 to 5, In GS Point, Santacruz East, Mumbai, MH, IND, 400 098
Camlin Fine Sciences Ltd is engaged in research, development, manufacturing, commercializing, and marketing of specialty chemicals and blends. These chemicals are used in food, feed, animal and pet nutrition and industrial products. The Company has only one reportable segment, namely, Speciality Chemicals. The company's product portfolio consists of Shelf life solutions, Aroma ingredients, Performance chemicals and Health & Wellness. Shelf life extension solutions include antioxidant solutions which are used to increase the shelf life of oils and. Aroma vertical includes a production of Vanillin and Ethyl Vanillin. Performance Chemicals consist of Guaiacol, Veratrole, TBC, and MEHQ and are used in sectors such as food flavoring, pharmaceuticals intermediate fragrance industry.
63GF Score

Get the complete analysis for NSE:CAMLINFINE

Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹102.80
Price
₹145.78
GF Value